Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

2G01

Pyrazoloquinolones as Novel, Selective JNK1 inhibitors

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeSYNCHROTRON
Source detailsAPS BEAMLINE 17-ID
Synchrotron siteAPS
Beamline17-ID
Temperature [K]110
Detector technologyCCD
Collection date2004-10-18
DetectorADSC QUANTUM 4
Spacegroup nameP 32 2 1
Unit cell lengths150.622, 150.622, 118.996
Unit cell angles90.00, 90.00, 120.00
Refinement procedure
Resolution19.890 - 3.500
R-factor0.286
Rwork0.283
R-free0.35400
Structure solution methodMOLECULAR REPLACEMENT
Starting model (for MR)1jnk JNK3 KINASE
RMSD bond length0.008
RMSD bond angle1.400
Data reduction softwareSDMS
Data scaling softwareHKL-2000
Phasing softwareCNX
Refinement softwareCNX (2002)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]20.0003.620
High resolution limit [Å]3.5003.500
Rmerge0.0650.365
Number of reflections15793
<I/σ(I)>27.92.6
Completeness [%]81.763.7
Redundancy5.85.3
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, HANGING DROP6.2277Protein was preincubated with the JIP1 peptide at a 5x molar excess. Protein concentration 9-12.6 mg/mL. Hanging drops consisted of 2uL protein plus 2uL well solution over 1 mL of well solution. Well solution: 2.8-3.1 M Ammonium Sulfate, 10-14% glycerol. For Co-crystallization experiment compound was dissolved in DMSO at 100 mM concentration. Allow to incubate for at least an hour on ice. Solution was spun for 5 minutes at 2000g prior to setting up for crystallization. , pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K

224931

PDB entries from 2024-09-11

PDB statisticsPDBj update infoContact PDBjnumon